Objectives: To compare the usage of solifenacin and fesoterodine in treatment of overactive bladder (OAB). 0.5 for Group 1 and 1.3 0.6 for Group 2 at week 12 (rating 3). Furthermore, no statistically factor was found between your ratings ( em p /em =0.062 (rating 1), em p /em =0.464 (rating 2), and em p… Continue reading Objectives: To compare the usage of solifenacin and fesoterodine in treatment